Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Gene Therapy Progress and Prospects: Recent progress in transgene and RNAi expression cassettes

Gene Therapy volume 12, pages 795–802 (2005)Cite this article

Abstract

Plasmid expression cassette design must include a thoughtful analysis of potentially every nucleotide comprising a covalently closed circular or end-protected linear DNA. This review will discuss recent studies in unraveling the mechanisms of postdelivery gene silencing, codon optimization and promoter identification. The recent discovery of potent RNA interference (RNAi) mechanisms for sequence-specific gene silencing has also invoked a great deal of interest in development of expression cassettes that can produce double-stranded RNA molecules for RNAi. Expression cassettes based on both RNA polymerase II and polymerase III transcription units that generate double-stranded RNA molecules for RNAi will also be discussed.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Niidome T, Huang L . Gene therapy progress and prospects: nonviral vectors. Gene Therapy 2002; 9: 1647–1652.

    Article  CAS  Google Scholar 

  2. Garmory HS, Brown KA, Titball RW . DNA vaccines: improving expression of antigens. Genet Vaccines Ther 2003; 1: 2.

    Article  Google Scholar 

  3. Rodriguez EG . Nonviral DNA vectors for immunization and therapy: design and methods for their obtention. J Mol Med 2004; 82: 500–509.

    Article  CAS  Google Scholar 

  4. Roth CM, Sundaram S . Engineering synthetic vectors for improved DNA delivery: insights from intracellular pathways. Annu Rev Biomed Eng 2004; 6: 397–426.

    Article  CAS  Google Scholar 

  5. Stacey KJ et al. The molecular basis for the lack of immunostimulatory activity of vertebrate DNA. J Immunol 2003; 170: 3614–3620.

    Article  CAS  Google Scholar 

  6. Chevalier-Mariette C et al. CpG content affects gene silencing in mice: evidence from novel transgenes. Genome Biol 2003; 4: R53.

    Article  Google Scholar 

  7. Chen ZY, He CY, Meuse L, Kay MA . Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo. Gene Therapy 2004; 11: 856–864.

    Article  CAS  Google Scholar 

  8. Trinh R, Gurbaxani B, Morrison SL, Seyfzadeh M . Optimization of codon pair use within the (GGGGS)3 linker sequence results in enhanced protein expression. Mol Immunol 2004; 40: 717–722.

    Article  CAS  Google Scholar 

  9. Available from Dr George Gutman, University of California, Irvine, CA, 92697. gagutman@uci.edu.

  10. Gao W et al. UpGene: application of a web-based DNA codon optimization algorithm. Biotechnol Prog 2004; 20: 443–448.

    Article  CAS  Google Scholar 

  11. Trinklein ND, Aldred SJ, Saldanha AJ, Myers RM . Identification and functional analysis of human transcriptional promoters. Genome Res 2003; 13: 308–312.

    Article  CAS  Google Scholar 

  12. Marino-Ramirez L, Spouge JL, Kanga GC, Landsman D . Statistical analysis of over-represented words in human promoter sequences. Nucleic Acids Res 2004; 32: 949–958.

    Article  CAS  Google Scholar 

  13. Malo MS et al. Improved eukaryotic promoter-detection vector carrying two luciferase reporter genes. Biotechniques 2003; 35: 1150–1154.

    Article  CAS  Google Scholar 

  14. Finn J, Lee AC, MacLachlan I, Cullis P . An enhanced autogene-based dual-promoter cytoplasmic expression system yields increased gene expression. Gene Therapy 2004; 11: 276–283.

    Article  CAS  Google Scholar 

  15. Hannon GJ . RNA interference. Nature 2002; 418: 244–251.

    Article  CAS  Google Scholar 

  16. Caplen NJ . Gene therapy progress and prospects. Downregulating gene expression: the impact of RNA interference. Gene Therapy 2004; 11: 1241–1248.

    Article  CAS  Google Scholar 

  17. Coburn GA, Cullen BR . siRNAs: A new wave of RNA-based therapeutics. J Antimicrob Chemother 2003; 51: 753–756.

    Article  CAS  Google Scholar 

  18. Clayton J . The silent treatment. Nature 2004; 431: 599–605.

    Article  Google Scholar 

  19. Wagner E . Strategies to improve DNA polyplexes for in vivo gene transfer: will ‘artificical viruses’ be the answer? Pharm Res 2004; 21: 8–14.

    Article  CAS  Google Scholar 

  20. Wells DJ . Gene therapy progress and prospects. Electroporation and other physical methods. Gene Therapy 2004; 11: 1363–1369.

    Article  CAS  Google Scholar 

  21. Schramm L, Hernandez N . Recruitment of RNA polymerase III to its target promoters. Genes Dev 2002; 16: 2593–2620.

    Article  CAS  Google Scholar 

  22. Brummelkamp TR, Bernards R, Agami R . A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296: 550–553.

    Article  CAS  Google Scholar 

  23. Paddison PJ et al. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev 2002; 16: 948–958.

    Article  CAS  Google Scholar 

  24. Sui G et al. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc Natl Acad Sci 2002; 99: 5515–5520.

    Article  CAS  Google Scholar 

  25. Paul CR, Good PD, Winer I, Engelke DR . Effective expression of small interfering RNA in human cells. Nat Biotech 2002; 20: 505–508.

    Article  CAS  Google Scholar 

  26. Yu JY, DeRuiter SL, Turner DL . RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci 2002; 99: 6047–6052.

    Article  CAS  Google Scholar 

  27. Miyagishi N, Taira K . U6 promoter-driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nat Biotech 2002; 19: 497–500.

    Article  Google Scholar 

  28. Lee NS et al. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotech 2002; 19: 500–505.

    Article  Google Scholar 

  29. Tran N, Cairns MJ, Dawes IW, Arndt GM . Expressing functional siRNAs in mammalian cells using convergent transcription. BMC Biotechnol 2003; 3: 21.

    Article  Google Scholar 

  30. Kaykas A, Moon RT . A plasmid-based system for expressing small interfering RNA libraries in mammalian cells. BMC Cell Biol 2004; 5: 16.

    Article  Google Scholar 

  31. Xia XG et al. An enhanced U6 promoter for synthesis of short hairpin RNA. Nucleic Acid Res 2003; 31: e100.

    Article  Google Scholar 

  32. Matsukura S, Jones PA, Takai D . Establishment of conditional vectors for hairpin siRNA knockdowns. Nucleic Acids Res 2003; 31: e77.

    Article  Google Scholar 

  33. Czauderna F et al. Inducible shRNA expression for applications in a prostate cancer mouse model. Nucleic Acids Res 2003; 31: e127.

    Article  Google Scholar 

  34. van de Wetering M et al. Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep 2003; 4: 609–615.

    Article  CAS  Google Scholar 

  35. Gupta S et al. Inducible, reversible, and stable RNA interference in mammalian cells. Proc Natl Acad Sci 2004; 101: 1927–1932.

    Article  CAS  Google Scholar 

  36. Cullen BR . Derivation and function of small interfering RNAs and microRNAs. Virus Res 2004; 102: 3–9.

    Article  CAS  Google Scholar 

  37. Bartel DP . MicroRNAs: genetics, biogenesis, mechanism, and function. Cell 2004; 116: 281–297.

    Article  CAS  Google Scholar 

  38. Lee Y et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004; 23: 4051–4060.

    Article  CAS  Google Scholar 

  39. Zeng Y, Wagner EJ, Cullen BR . Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Mol Cell 2002; 9: 1327–1333.

    Article  CAS  Google Scholar 

  40. Zeng Y, Cullen BR . Sequence requirements for micro RNA processing and function in human cells. RNA 2003; 9: 112–123.

    Article  CAS  Google Scholar 

  41. Krol J et al. Structural features of microRNA (miRNA) precursors and their relevance to miRNA biogenesis and small interfering RNA/short hairpin RNA design. J Biol Chem 2004; 279: 42230–42239.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Division, CancerVax® Corporation, Carlsbad, CA, USA

    C R Ill

  2. Research and Development, Proteomics Segment, Invitrogen Corporation, Carlsbad, CA, USA

    H C Chiou

Authors
  1. C R Ill
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H C Chiou
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ill, C., Chiou, H. Gene Therapy Progress and Prospects: Recent progress in transgene and RNAi expression cassettes. Gene Ther 12, 795–802 (2005). https://doi.org/10.1038/sj.gt.3302524

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3302524

Keywords

This article is cited by

Search

Advanced search

Quick links